Mucin 1 deficiency mediates corticosteroid insensitivity in asthma
Impact
Scholar |
Other documents of the author: MILARA, JAVIER; Morell, Anselm; de Diego, Alfredo; Artigues, Enrique; Morcillo, Esteban; Cortijo, Julio
Metadata
Show full item recordcomunitat-uji-handle:10234/9
comunitat-uji-handle2:10234/36080
comunitat-uji-handle3:10234/36082
comunitat-uji-handle4:
INVESTIGACIONThis resource is restricted
https://doi.org/10.1111/all.13546 |
Metadata
Title
Mucin 1 deficiency mediates corticosteroid insensitivity in asthmaAuthor (s)
Date
2019-01Publisher
WileyISSN
0105-4538; 1398-9995Bibliographic citation
MILARA, Javier, et al. Mucin 1 deficiency mediates corticosteroid insensitivity in asthma. Allergy, 2019, vol. 74, no 1, p. 111-121Type
info:eu-repo/semantics/articlePublisher version
https://onlinelibrary.wiley.com/doi/abs/10.1111/all.13546Version
info:eu-repo/semantics/publishedVersionSubject
Abstract
BACKGROUND:
The loss of corticosteroid efficacy is an important issue in severe asthma management and may lead to poor asthma control and deterioration of airflow. Recent data indicate that Mucin 1 (MUC1) membrane ... [+]
BACKGROUND:
The loss of corticosteroid efficacy is an important issue in severe asthma management and may lead to poor asthma control and deterioration of airflow. Recent data indicate that Mucin 1 (MUC1) membrane mucin can mediate corticosteroid efficacy in chronic rhinosinusitis, but the role of MUC1 in uncontrolled severe asthma is unknown. The objective was to analyze the previously unexplored role of MUC1 on corticosteroid efficacy in asthma.
METHODS:
Mucin 1 expression was evaluated by real-time PCR in human bronchial epithelial cells (HBEC) and blood neutrophils from uncontrolled severe asthma (n = 27), controlled mild asthma (n = 16), and healthy subjects (n = 13). IL-8, MMP9, and GM-CSF were measured by ELISA in HBEC and neutrophils. An asthma model of ovalbumin (OVA) was used in MUC1 KO and WT C57BL/6 mice according to ARRIVE guidelines.
RESULTS:
Mucin 1-CT expression was downregulated in bronchial epithelial cells and peripheral blood neutrophils from severe asthma patients compared with mild asthma and healthy subjects (P < 0.05). Daily dose of inhaled corticosteroids (ICS) inversely correlated with MUC1 expression in neutrophils from mild and severe asthma (ρ = -0.71; P < 0.0001). Dexamethasone showed lower anti-inflammatory effects in severe asthma peripheral blood neutrophils and HBECs stimulated with lipopolysaccharide (LPS) than in cells from mild asthma. Glucocorticoid receptor (GR)-α phosphorylated at serine 226 was increased in cells from severe asthma, and the MUC1-CT/GRα complex was downregulated in severe asthma cells. OVA asthma model in MUC1 KO mice was resistant to the anti-inflammatory effects of dexamethasone.
CONCLUSION:
Mucin 1-CT modulates corticosteroid efficacy in vitro and in vivo asthma models. [-]
Is part of
Allergy, 2019, vol. 74, no 1Investigation project
Ministerio de Ciencia e Innovacion: SAF2015-65368-R; SAF2017-82913-R; TRA2009-0311; Instituto de Salud Carlos III: CB06/06/0027; FIS PI14/01733; FIS PI17/02158; GOBIERNO REGIONAL COMUNIDAD VALENCIANA: Prometeu/2017/023/UVRights
© EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.
http://rightsstatements.org/vocab/InC/1.0/
info:eu-repo/semantics/restrictedAccess
http://rightsstatements.org/vocab/InC/1.0/
info:eu-repo/semantics/restrictedAccess
This item appears in the folowing collection(s)
- MED_Articles [632]